Table Of Content

VOLUME 42 1992 SUBJECT INDEX Alcohol, 605 Behavioral sensitization, 179 Cockerel, 535 Abecarnil, 401 Benzodiazepine receptor(s), 107, 517 Cognition, 75 Absence epilepsy, 401 Benzodiazepine(s), 605, 761, 787, 865 Color and position discrimination, 333 Abstinence, 327 B-Adrenergic blocking agents, 465 Conditioned fear, 437 Abstinence signs, 29 B-Adrenoceptors, 791 Conditioned place preference, 445 Abuse, 389 B-Carboline, 401, 733 Conditioned suppression, 625 Accumbens, 421 @B-Funaltrexamine, 29 Conditioned taste aversion, 487 Acetylcholine, 749 Bifemelane hydrochloride, 721 Conflict behavior, 733 Acetylcholinesterase, 131 Biological models, 787 Contrast, 111 Active avoidance, 285 Biphasic effect, 257 Control of food intake, 541 Active avoidance conditioning, 523 Blood pressure, 465 Controllability, 437 Active avoidance task, 119 BMY 7378, 481 Core body temperature, 549 Acute bout of exercise, 67 Brain dopamine metabolism, 261 Cortex, 749 Acute tolerance, 347, 831 Brain-gut interactions, 541 Cortical thickness, 741 Adenosine agonists, 201 Brain-gut peptides, 541 Cotinine, 327 Adrenalectomy, 685 Brain lesions, 711 Coulometric detector, 351 Adrenergic receptors, 1 Brain stimulation reward, 771 Cross-adaptation, 407 Adverse side effects, 465 Brainstem, 9 Crown ether ionophores, 645 AF64A, 119 Brightness discrimination learning test, 721 Crustacea, 323 Aggression, 193, 809 Butorphanol, 29 Aggressive behavior, 35 d-Amphetamine, 57, 497, 765, 871 Alcohol, 749 Caffeine, 143, 155, 431, 633, 651 Defense, 317 Alenolol, 465 Carbamazepine, 843 Defense response, 323 Allopurinol, 899 Cardiovascular, 155 Defensive behavior, 25 a,-Adrenergic receptors, 97 Cardiovascular arousal, 301 Delayed-matching-to-sample, 871 a,-Adrenoceptor, 693 Cardiovascular effects, 791 6-9-Tetrahydrocannabinol, 269 a,-Adrenoceptor antagonist, 197 Catalepsy, 545, 803 Dentate gyrus, 85 a-Adrenoceptors, 791 Cathinone, 619 Dependence, 815 Alprenolol, 529 Caudate, 421 Depression, 737 (-)-Alprenolol, 49 CCK-A, 699 des-Tyr'-Leu-Enk, 613 Aminorex, 175 CCK-B, 699 des-Tyr'-Met-Enk, 613 Amphetamine, 143, 175, 421, 563, 633, 705 CCK-8, 291 Development, 413, 535 Anabolic steroids, 809 CCK-JMV-180, 291 Developmental toxicology, 169 Analgesia, 229, 685 CDP, 487 Dexfenfluramine, 855 Anhedonia, 219 Central stimulants, 179 DFP, 131 Animal models, 737 Cerebral asymmetry, 457 Diaschisis, 705 Anorectics, 699 CGRP, 545 Diazepam, 297 Anorexia, 97 Chewing, 381 Diazepam-insensitive receptors, 107 Antagonism, 473, 587 Chicken, 535, 823 Diazepam-sensitive receptors, 107 Antihypertensive agents, 465 Chlorpromazine, 111, 333 Diazepan, 711 Anxiety, 143, 733 Chlorpyrifos, 251 Diet selection, 343 Anxiogenic agents, 733 Cholecystokinin, 541, 699 Dietary fat, 343 Anxiolytics, 143, 487 Choline acetyltransferase, 119 Differential outcomes effect, 871 APS, 229 Choline acetyltransferase activity, 19 Discrimination stimulus, 619 Apomorphine, 61 Cholinergic agents, 119 Discriminative responding, 57 Arginine vasotocin, 823 Cholinergic receptors, 1 Diuresis, 1 Aromatase inhibitor, 823 Cholinesterase inhibition, 251 DOI, 413 A-70104, 699 Chronic administration, 297 Domestic fowl, 535, 781 A-71623, 699 Chronic cocaine, 771 Domestication, 25 ATD, 823 Chronic ethanol, 831 D,, 163 Atipamezole, 197, 903 Chronic stress, 407 D, and D, dopaminergic receptors, 213 Atropine, 633, 711 Chronic tolerance, 347, 831 D, and D, receptors, 261 Attenuation of morphine abstinence syn- Cigarette smoking, 327 D, dopamine receptor, 755 drome, 693 Cirazoline, 97 DOPAC, 269 Atypical neuroleptic, 559 Climbing, 261 Dopamine, 57, 163, 257, 269, 381, 421, Avian, 535 Clomipramine, 737 451, 457, 509, 559, 765, 781, 859, 889 Avoidance learning, 389 Clonazepam, 297 Dopamine receptor(s), 791, 803 Clonidine, 313, 563 Dopaminergic receptors, 269 Baboon(s), 465, 497 Clorgyline, 421 Dopaminergic system, 545 Basal forebrain, 119 Clozapine, 559 Dorsal immobility response, 257, 613 Basal forebrain lesion, 19 Cocaine, 169, 481, 509, 559, 889 Dorsal striatum, 613 Behavior, 285, 327, 401, 413, 711, 815 Cocaine A-9 THC, 497 Dowel test, 831 Behavioral challenge, 301 Cocaine hydrochloride, 849 Drinking, 381 Behavioral genetics, 579 Cocaine tolerance, 771 Drug abuse, 169, 175, 771 909 910 SUBJECT INDEX Drug concentration, 579 Ginseng total saponins, 587 Long-term potentiation, 843 Drug discrimination, 175, 487 Glutamate antagonist, 229 Lordosis, 879 Drug effects, 183 Glycine, 229 l-Phenylisopropyl adenosine, 651 Drug reinforcement, 579 Glycine receptors, 229 LTP, 85 Drug self-administration, 579 Gonadal steroids, 823 Drugs, 497 Gonadectomy, 685 Macronutrient selection, 343 D,, 163 Guinea pig, 183, 285 Male rats, 445 D, dopamine receptor, 755 Marmoset, 75, 143 D, receptor, 257 Haloperidol, 111, 187, 381, 457, 797, 803 MDL 73,147EF, 519 Dynorphin A(1-13), 755 Hamster, 879 Measure stability, 245 Dysphoria, 771 Heart rate conditioning, 633 Medial septum, 277 High-affinity choline uptake, 553, 749 Median raphe nucleus, 25 EEG, 401, 711 High-performance liquid chromatography, Membrane physiology, 645 EEG power spectra, 815 351 Memory, 749, 761 8-OH-DPAT, 413, 487, 529, 541 Hippocampus, 25, 277, 553, 749, 843, 899 Mental performance, 155 Eltoprazine (DU 28853), 317 Hippocampus slices, 85 Mesotocin, 823 Embryo, 823 Holeboard, 407 Met-enkephalin, 91 Enkephalin fragments, 523 Hot plate, 535, 865 Met°-Enk, 613 Epilepsy, 899 Hydrochlorothiazide, 497 Methadone, 91, 685 Ethanol, 35, 187, 347, 389, 473 Hyperalgesia, 229, 535, 781 Methadone dependent, 91 Ethanol withdrawal, 831 Hypoalgesia, 781 Methamphetamine, 389, 791 Ethosuximide, 871 Hypomotility, 545 Methysergide, 661, 671 Ethyl alcohol, 787 Hypothalamic-anterior pituitary area, 269 Mice, 101, 193, 523, 749, 797 Etonitazene, 579 Hypothalamus, 823 Microcomputer, 327 Etonitazene reinforcement, 579 Hypothermia, 605 Microdialysis, 421 Euphoria, 771 Mini-Mitter, 549 Experimental design, 761 ICS-205,930, 661, 671 Monkey, 197, 333 Exploratory activity, 313 Inbred strains of mice, 261 Monoamine contents, 119 Extrapyramidal side effects, 381 Indalpine, 45 Monoamine neurotransmitters, 351 Infant rats, 855 Monoamines, 781 Feeding, 207, 219, 699 - Infantile sexual segregation, 865 Morphine, 91, 323, 451, 535, 685, Fenfluramine, 175 Inhibition of aspartate/glutamate release, 781, 815 FG-7142, 317 693 Morphine dependent, 91 Fighting behavior, 35 Inhibitory amino acid, 229 Morris’s water maze, 19 Fischer 344 rats, 579 Injection, 193 Morris water maze task, 119 Five-choice serial reaction time task, 903 Insulin hyperphagia, 671 Motivation, 333 5-HT reuptake inhibition, 49 Intensification of morphine dependence, Motor activity, 251, 497, 605 5-HT syndrome, 413 693 Motor behavior, 465 5-HT,,, 25 Interferon-a, 57 Motor incoordination, 473 5-HT,, blockade, 49 Intracerebroventricular, 473, 619 Mouse, 755, 865 5-HT,, receptors, 541 In utero, 509 Mouse brain areas, 351 5-HT; receptor antagonist, 75 In vivo microdialysis, 765 Multiple maze, 101 5-HT; receptors, 519 In vivo voltammetry (electrochemistry), Multiple schedule, 849 5-HTP, 529 889 Multiple-variable interval 15-s extinction 5-Hydroxytryptamine, 413 Ionizing radiation, 233 schedule, 721 5-Hydroxytryptophan, 413 Ischemia, 705 Muscarinic receptors, 131, 251 5,7-Dihydroxtryptamine, 481 Isolation-induced attack, 317 Fixed interval, 563, 849 Naloxone, 57, 323, 535, 613, 765 Fixed ratio, 849 Kaliuresis, 1 Naloxone-precipitated withdrawal, 91 Fixed-ratio size, 579 Ketamine, 347 Naltrexone, 661, 671, 685 Flavor history, 651 Key-peck, 849 Natriuresis, 1 Flumazenil, 787 K function, 245 Neonatal, 741 Flunitrazepoam, 787 Kindling, 899 Neurohypophysis, 823 Fluoxetine, 45, 187 Neuroleptic, 111 Flurazepam, 111, 517, 681 Lactate, 67 Neuropeptide Y, 207 Flutamide, 823 Latent inhibition, 519, 625 Neurosteroid, 605 Food intake, 291 Lateral hypothalamus, 563 Neurotoxicity, 855 Food-reinforced behavior, 207 Learning, 333 Neurotransmitters, 389 Foot-shock, 633 [LeuJenkephalin, 523 Nicotine, 131, 327, 633 Forced swim, 407 Leu5-Enk, 613 Nicotine receptors, 131 Forced swimming test, 737 Lewis inbred rat strain, 815 Nigrostriatal pathway, 213 Formalin test, 781 Lewis rats, 579 NMDA antagonist(s), 183, 347 Frontal cortex, 553 L-glutamic acid decarboxylase, 119 NMDA receptor, 229 Frontoparietal cortex, 19 LHRH, 445 NMDA receptor antagonists, 179 F344 inbred rat strain, 815 Limbic, 9 Nociception, 535, 781 Limbic forebrain, 269 Noise, 553 GABA, 107, 859, 879 Lithium, 431 Noncholinergic agents, 119 GABA-benzodiazepine receptors, 787 Lithium chloride, 633 Nonhuman primates, 465, 497 Gender, 301 Litoxetine, 45 Noradrenergic activity, 407 Generalization, 619 Locomotion, 9, 421, 509 Noreleagnine, 733 Genetic differences, 579 Locomotor activity, 261, 291, 755, 765, Norepinephrine, 781, 859 Genetics, 131, 219 865 Novel object, 865 SUBJECT INDEX N°-cyclohexyladenosine, 431 Radioprotection, 233 Spontaneous learning, 101 Nucleus accumbens, 619, 765 Rapid eye movement sleep, 49 Spontaneous motor activity, 473 Rat(s), 19, 61, 91, 207, 233, 381, 401, 437, Sprague-Dawley rats, 245 Object discrimination task, 75 481, 619, 625, 651, 903 Squirrel monkeys, 791 Olfactory learning, 169 Rat masculine sexual behavior, 529 Startle response, 831 Ondansetron, 75, 849 Rat pup, 163 Stereotypy, 421, 509 Ontogeny, 535 Receptor upregulation, 685 Stimulants, 9 Open-field test, 831 Recovery of function, 705 Stimulus control, 871 Operant behavior, 233, 333 Rectal probe, 549 Stress, 193, 219, 431, 437, 517, 681 Opiate(s), 9, 41, 535, 781 Rectal temperature, 831 Striatum, 269, 509, 765 Opiate dependence, 201 Reference memory, 101 Stroop task, 155 Opiate withdrawal, 201 Reinforcement, 889 Subjective stress, 301 Opioid(s), 57, 323, 579, 685, 781 Related metabolites, 351 Sucrose, 111 Opioid peptides, 523 Renin, 481 Sulpiride, 163, 213 Opioid receptors, 29, 685 Renovascular hypertension, 465 Supersensitivity, 685 Opioid receptor subtypes, 553 Respiration, 535 Swiss-Webster mice, 35 Oral route, 579 Retention, 523 Sympathetic ingrowth, 277 Organophosphate, 251 Reward, 9, 163, 169 Synaptic inhibition, 843 Oxiracetam, 797 Reward summation, 563 Synaptic plasticity, 85 Oxotremorine, 549 Righting reflex, 183 Oxytocin, 61 Ritanserin, 661, 671 Tail-flick test, 831 Ro 15-4513, 107, 473 Tail suspension test, 45 Pain, 229 Ro 15-1788, 733 Tamoxifen, 823 Paroxetine, 45 Ro 5-4864, 297 Taste aversion learning, 633 Passive avoidance, 797, 859 Rotational behavior, 213 Testing environment, 317 Penile erection, 61 RU 24213, 755 Testosterone propionate, 809 Pentobarbital, 605, 633 TFMPP, 529 Pentylenetetrazol, 733 Salicylate, 549 Thirst, 1, Pentylenetetrazole, 143, 605 Satiety, 541 [H]Ro 5-4864 binding, 297 Performance decrement, 233 Schedule-induced polydipsia, 381 Time dependent, 445 Peripheral benzodiazepine receptor, 437 Schizophrenia, 519, 625 Time perception, 333 Phenocyclidine, 625 SCH 23390, 163, 213, 381 Time structure, 245 Phenylpropanolamine, 97 Scopolamine, 75, 101, 251, 285 Tizanidine, 693 Phosphoinisitol metabolism, 277 Sedation, 761 Tolerance, 131, 179, 815 Physostigmine, 67, 285, 749 Seizures, 517, 681 Trachea, 645 Pigeons, 849, 871 Selective, 473 Trimethyltin, 313 Pimozide, 563 Selective attention, 903 Tryptophan-deficient rats, 721 Pindolol, 809 Self-administration, 187, 559 Two-bottle test, 651 Pineal gland, 823 Self-stimulation, 451, 563 2-Deoxy-D-glucose hyperphagia, 661 Piracetam, 859 Self-stimulation threshold, 771 Tyr-Gly-Gly, 523 Pirenpirone, 809 Sensitization, 421 Pizotyline, 809 Serotonergic activity, 407 U-50,488H-induced antinociception, 587 Plasticity, 741 Serotonergic mechanisms, 587 Ulceration, 431 Porsolt’s swim test, 193 Serotonin, 25, 49, 481, 541, 559, 781, 855, Unilateral cerebral drug administration, Posttraining administration, 523 859, 889 457 Posture, 595 Serotonin receptors, 661, 671 Untrained and trained, 67 Practolol, 529 Sex differences, 685 Prandial drinking, 651 Sexual behavior, 41, 197, 879 Ventral tegmentum, 889 Prazosin, 97, 849 Sexual differentiation, 41, 823 Verapamil, 497 Predictability, 437 Short-term memory, 333 Vertiginous syndromes, 595 Prefrontal cortex, 451 Shuttlebox, 285 Vestibular nuclei, 595 Pregnancy, 855 6-Hydroxydopamine, 187, 741, 803 Vestibuloocular reflex, 595 Pregnanolone, 605 6-OHDA, 213 Viconate, 19 Pregnenolone sulfate, 605 SK&F 38393, 755 Vinca alkaloid, 19 Prenatal ethanol intoxication, 85 SKF38393, 213 VTA, 879 Progesterone, 879 Sleep, 401 Progressive ratio, 559 Sleep time, 605 Waking, 49 Prolactin, 269 Slow-wave sleep, 49 Water intake, 1 Propranolol, 465 Smoking, 155, 301 Wild rat, 25 Psychomotility, 431 Smooth muscle, 645 WR-3689, 233 Psychostimulant behavior, 889 Social development, 865 WR-2721, 233 Puff parameters, 327 Social isolation, 35 Pyruvate, 67 Soman, 711 Yawning, 61 Spatial learning, 19, 741 Yohimbine, 317, 481, 693 Quinine, 651 Species comparisons, 291, 699 Quinpirole, 179, 257 Spiperone binding, 803 Zimeldine, 45, 49 Quipazine, 809 Spontaneous behavior, 245 ZK 112 119, 401 VOLUME 42 1992 AUTHOR INDEX Abe, E., 351 Condon, K. T., 741 Grobe, J. E., 301 Kolbeck, R. C., 645 Aguirre, A., 645 Connor, D. J., 277 Gronroos, M., 197 Kolonen, S., 327 Airaksinen, M. M., 327 Corbett, D., 451, 705 Komisaruk, B. R., 229 Allen, P. M., 605 Costall, B., 75, 143 Haapalinna, A., 903 Koyuncioglu, H., 693 Allen, R. P., 465, 497 Cottrell, G. A., 613 Hammer, Jr., R. P., 25 Kubota, T., 843 Alling, K., 871 Coupar, I. M., 201 Hara, T., 431 Kuczenski, R., 421 Ally, A., 741 Crawford, C. A., 163 Harrell, L. E., 277 Anisman, H., 219 Hasegawa, H., 899 La Neave, C., 645 Ariciédglu, F., 693 Dar, M. S., 473 Hasegawa, T., 19 Lai, H., 553 Argiolas, A., 61 Darlington, C. L., 183 Hasenfratz, M., 155 Laventure, S. I., 741 Armario, A., 407 Davies, B. T., 91 Hatake, K., 389 Laviola, G., 865 Aroor, A. R., 859 De Beun, R., 445 Heyser, C. J., 169 Leite, D. F., 1 Asin, K. E., 291, 699 DeBold, J. F., 879 Hienz, R. D., 465, 497 Levin, V. A., 57 Atrens, D. M., 563 de Groot, D. M. G., 711 Hijzen, T. H., 487 Levine, A. S., 207 Ayyagari, V., 277 De Luca, Jr., L. A., 1 Hilakivi-Clarke, L. A., 193 Levy, A. D., 481 De Montis, M. G., 179 Hill, T. J., 733 Li, Q., 481 Babu, S. R., 67 Deutsch, S. I., 517, 681 Hishida, S., 389 Linnankoski, I., 197 Bartke, A., 269 Devauges, V., 313 Hiyama, Y., 213 Loggi, G., 865 Battaglia, G., 481 Devoto, P., 179 Ho, B. T., 57 Loh, E. A., 559 Battaglia, M., 797 Diana, G., 297 Ho, I. K., 29 Lopez-Colomé, A. M., 229 Battig, K., 155 Diaz Ruiz, O., 737 Hoganson, D. A., 781 Lu, J.-G., 57 Bechara, A., 9 Dilsaver, S. C., 549 Holmes, P. V., 437 Lukacs, L. G., 681 Beck, C. H. M., 381 Dingwall, B., 183 Holtzman, S. G., 765 Lutfy, K., 685 Becker, H. C., 111 Dionyssopoulos, T., 201 Hooks, M. S., 765 Lyness, W. H., 187 Beczkowska, I. W., 661, 671 Dizdar, Y., 693 Hope, W., 201 Bednarz, L., 291, 699 Domeney, A. M., 75, 143 Hopper, D. L., 245 Maezono, Y., 119 Beracochea, D., 749 Drago, F., 545 Hori, K. M., 25 Makhay, M., 871 Bergamo, P., 323 Drugan, R. C., 437 Hoskins, B., 29 Makimura, M., 29 Beyer, C., 229 Duttaroy, A., 685 Hughes, R. A., 535, 781 Maldonado, H., 323 Hunt, G. E., 563 Bezold, H. J., 465 Malherbe, E., 595 Billings, B., 685 Esin, Y., 693 Huo, Y.-Y., 57 Manderscheid, P. Z., 771 Bjorvatn, B., 49 Hyde, J. F., 457 Marks, P. A., 823 Blakely, E., 871 Farrar, J. D., 251 Martin, R. J., 343 Blanchard, D. C., 25 Feldon, J., 625 Inturrisi, C. E., 685 Martinez, Jr., J. L., 523 Blanchard, R. J., 25 Ferguson, S. A., 333 Ishihara, T., 119 Martin-Iverson, M. T., 381 Bodnar, R. J., 661, 671 Fernandez-Guasti, A., 529 Itoh, T., 101, 351 Massotti, M., 297 Bonson, K. R., 809 Fernandez-Ruiz, J. J., 269 Iwata, S.-I., 803 Mastropaolo, J., 517, 681 Bowes, M. P., 245, 535 File, S. E., 761 Izumi, K., 803 Masuda, Y., 101, 351 Breus, M., 301 Fiore, C. E., 545 Matsuda, H., 213 Broderick, P. A., 889 Firestone, L. L., 787 Jaffard, R., 749 Matsumoto, K., 213 Brown, K., 651 Fitch, T., 559 Jakala, P., 903 Mayo-Michelson, L., 815 Buckenmeyer, P., 67 Flaherty, C. F., 111 Jansen, E., 445 McCloskey, T. C., 733 Foglia, S., 1 Jaw, S. P., 29 McDonough, J. H., 233 Caba, M., 229 Fontana, D. J., 733 Jerussi, T. P., 457 McDougall, S. A., 163 Cabrera, T. M., 481 Fonte, C., 301 Jewett, D. C., 207 Meisch, R. A., 579 Calcagnetti, D. J., 619 Frank, R. A., 771 Jibiki, I., 843 Melchers, B. P. C., 285, 711 Camargo, L. A.A., 1 Franz, C. G., 233 Johnston, H. M., 41 Melchior, C. L., 605 Campmany, L., 407 Frye, C. A., 879 Jones, D. N. C., 75, 143, 765 Mele, P. C., 233 Candido, J., 685 Fujimoto, K., 843 Justice, Jr., J. B., 765 Melis, M. R., 61 Carey, G. J., 75, 143 Fulginiti, S., 85 Meloni, D., 179 Carino, M. A., 553 Kalant, H., 347 Menani, J. V., 1 Carlson, S., 197 Gambarana, C., 179 Kameyama, T., 19, 755 Messing, R. B., 313 Castellano, C., 797 Geerts, N. E., 445 Kaminski, B. J., 497 Meyer, M. E., 257 Cebeira, M., 269 George, F. R., 579 Karanth, K. S., 859 Meyer, M. E., 257, 613 Chakraborti, T. K., 251 Gerrard, P. A., 75 Kemble, E. D., 317 Micheau, J., 749 Chapman, M. L., 251 Gibbs, J., 541 Kernan, W. J., 245 Millard, W. J., 509 Chat, M., 595 Gil, M., 407 Kerr, J. E., 481 Minematsu, N., 431 Chau, A., 347 Gilmore, D. P., 41 Khanna, J. M., 347 Miralto, A., 323 Checke, S., 111 Giorgi, G., 179 Kim, H.-S., 587 Mizuki, Y., 431 Cleary, J., 207 Goldberg, S. R., 791 Kim, S.-H., 587 Mokler, D. J., 413 Clementi, G., 545 Gomez, R. A., 85 Kinoshita, H., 19 Moody, C. A., 169 Coenen, A. M. L., 401 Goodwin, G. A., 169 Kinzler, S. L., 823 Moran, P. M., 519 Colbourne, F., 705 Gore, Jr., P. A., 699 Knowlton, R. G., 67 Morel, E., 45 Coleman-Hardee, M., 509 Grassi, M., 545 Koch, J. E., 661, 671 Moser, P. C., 519 Collins, A. C., 131 Griffiths, J., 219 Koike, T. I., 823 Mullen, B. J., 343 Commissaris, R. L., 733 Grigson, P.S., 111 Kokoris, D., 771 Murai, S., 101, 351 914 AUTHOR INDEX Murakami, H., 101 Perrault, GH., 45 Sansone, M., 797 Turkkan, J. S., 465, 497 Murphy, L. L., 269 Pertovaara, A., 197 Sara, S. J., 313 Tyers, M. D., 75 Murtha, S. J. E., 741 Philippens, I. H. C. H. M., Sayag, N., 823 285, 711 Schaal, D. W., 207 Ukai, M., 755 Nabeshima, T., 19 Pierce, T. L., 91 Schechter, J. B., 619 Uresin, Y., 693 Nadzan, A. M., 699 Poeschla, B., 541 Schechter, M. D., 619 Ursin, R., 49 Nakamura, M., 899 Pohorecky, L. A., 831 Schindler, C. W., 791 Ushijima, I., 431 Nakamura, S., 119 Pol, O., 407 Schlinger, H., 871 Nalini, K., 859 Poling, A., 871 Schulteis, G., 523 Valerio, C., 545 Naylor, R. J., 75, 143 Pope, C. N., 251 Scott, S. J., 183 Van De Kamp, J. L., 131 Neckelmann, D., 49 Popova, N. K., 261 Segal, D.S., 421 Van De Kar, L., 481 Newland, M. C., 651 Potter, T. J., 257 Shah, G., 347 Van De Poll, N. E., 445 Nickel, M., 871 Prato, A., 545 Shanks, N., 219 Van Der Kooy, D., 9 Nikkel, A. L., 699 Puustinen, P., 327 Sierra, V., 685 van Haaren, F., 849 Nikulina, E. M., 261 Simansky, K. J., 541 Van Hartesveldt, C., 257, 613 Nomoto, M., 803 Quinlan, J. J., 787 Sirvio, J., 903 Van Hest, A., 487 Nomura, M., 721 Skolnick, P., 107 Van Luijtelaar, E. L. J. M., Nonneman, A. J., 163 Ramirez, O. A., 85 Skrinskaya, J. A., 261 401 Norris, D. O., 517, 681 Ramos, J. A., 269 Slangen, J. L., 445, 487 Velazquez-Moctezuma, J., Nosek, T. M., 645 Rao, A., 859 Smith, F. L., 187 737 Rawleigh, J. M., 317 Smith, G. P., 541 Vickers, G., 559 Obara, N., 431 Reeve, B., 183 Smith, P. F., 183 Vidal, P.-P., 595 O’Connor, D. A., 517, 681 Reilly, S., 633 Somani, S. M., 67 Oh, K. W., 29 Renzi, A., 1 Spear, D. J., 497 Wada, Y., 899 Oh, K.-W., 587 Revusky, S., 633 Spear, L. P., 169 Watanabe, H., 213 Ohno, T., 119 Rheu, H.-M., 587 Stancampiano, R., 61 Weiner, I., 625 Okuda, C., 421 Riekkinen, Jr., P., 903 Steger, R. W., 269 Weiner, J., 347 Olivier, B., 487 Riekkinen, P., 903 Stephens, D. N., 401 Wellman, P. J., 91 Olley, J. E., 91 Rittenhouse, P. A., 481 Stringer, A. P., 437 Williams, H. P., 771 Ouchi, H., 389 Roberts, D. C. S., 559 Sufka, K. J., 535, 781 Winter, J. C., 809 Overstreet, D. H., 549 Roberts, P., 831 Sullivan, S. A., 413 Winterson, B. J., 413 Robertson, R. M., 855 Suzuki, T., 579 Wolthuis, O. L., 285 Paivarinta, P., 35 Robinzon, B., 823 Szirtes, R. M., 741 Wolthuis, O. L., 711 Panicker, S., 771 Rodriguez De Fonseca, F., Wong, G., 107 Pannell, K. H., 645 269 Tagliamonte, A., 179 Pappas, B. A., 741 Rodriguez-Manzo, G., 529 Tani, Y., 119 Yabe, T., 595 Park, C. H., 681 Roman, M., 871 Taniguchi, T., 389 Yamada, M., 431 Park, G. A. S., 741 Rowan, G. A., 111 Tansey, L. W., 57 Yamaguchi, N., 843, 899 Parsons, D. S., 277 Rowland, N. E., 855 Tella, S. R., 791 Yamamura, T., 389 Paule, M. G., 333 Terasawa, K., 213 Yoburn, B. C., 685 Payne, A. P., 41 Saad, W.A., 1 Thompson, T., 207 Young, G. A., 815 Peagler, A., 277 Saito, H., 351 Tiong, G. K. L., 91 Young, R., 175 Peck, J. A., 549 Sanger, D. J., 45 Todd, K. G., 381 Peris, J., 509 Sannerud, C. A., 497 Toyoshi, T., 755 Zheng, J.-W., 791 Perkins, K. A., 301 Sansom, A. J., 183 Tuomisto, J., 327 Zivkovic, B., 45